Assessment of correlation between serum βTP and cystatin C as biomarkers for the detection of early nephropathy in Iraqi patients with type 2 diabetes
Keywords:
βTP, Cystatin C, Diabetic Nephropathy, Type 2-diabetes mellitusAbstract
Background: Diabetic nephropathy (DN) is one of the most well-known diabetic microvascular complications, affecting around 40% of individuals with type 2 diabetes mellitus (T2DM). It progresses to end-stage renal disease (ESRD), and its primary detection can be done via diabetes biomarkers. The power of early biomarker identification of DN in T2DM serum is evaluated in this study. Aim: This study aimed to assess the possibility of using ΒTP and Cys. C as earlier markers for the detection of nephropathy in patients with type 2 DM. Materials and Methods: This is a cross-sectional study. It included one hundred twenty patients with T2DM, composed of 66 males and 45 females, and aged 40–69 years, who were divided into 3 groups by using the urinary albumin/creatinine ratio (ACR): Group I: (N = 40 Normoalbuminuria UACR < 30 mg/g as control), Group II: (N = 40 Microalbuminuria UACR 30–300 mg/g), Group III: (N = 40 Macroalbuminuria UACR ˃ 300 mg/g). In all groups, βTP and Cys. C were estimated in the serum of patients, and both biomarkers had the same methodology by quantitative enzyme immunoassay (double-antibody sandwich).
Downloads
References
Amer AH, Haridas N. Early Diagnostic Markers in Diabetic Nephropathy Patients. Journal of Clinical & Diagnostic Research. 2018;12(11).
Chakraborty D, Akbari A, Knoll GA, Flemming JA, Lowe C, Akbari S, et al. Serum BTP concentrations are not affected by hepatic dysfunction. BMC nephrology. 2018;19(1):1-6.
Control CfD, Prevention. Chronic kidney disease in the United States, 2019. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention. 2019:3.
Ebert N, Shlipak MG. Cystatin C is ready for clinical use. Current Opinion in Nephrology and Hypertension. 2020;29(6):591-8.
Elsayed MS, El Badawy A, Omar R, Mohamed A. Serum cystatin C as an indicator for early detection of diabetic nephropathy in type 2 diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019;13(1):374-81.
Enko D, Meinitzer A, Scharnagl H, Stojakovic T, Kleber ME, Delgado GE, et al. Prospective cohort studies of beta-trace protein and mortality in haemodialysis patients and patients undergoing coronary angiography. Nephrology Dialysis Transplantation. 2018;33(11):1984-91.
Handayani R, Widaningsih Y, Mangarengi F, Bahrun U. Serum Beta-Trace Protein versus Glomerulus Filtration Rate as a Predictor for Kidney Function among Hypertensive Patients. Indonesian Journal Of Clinical Pathology And Medical Laboratory. 2021;27(2):127-31.
Hebah HA, Afifi EN, Abd El-Megeid SZ, Al-Raddad MM. Beta-trace protein as an early predictor of diabetic nephropathy in type II diabetes. Journal of The Egyptian Society of Nephrology and Transplantation. 2018;18(3):96.
Leto G, Crescimanno M, Flandina C. On the role of cystatin C in cancer progression. Life sciences. 2018;202:152-60.
Leyssens K, Van Regenmortel N, Roelant E, Guerti K, Couttenye MM, Jorens PG, et al. Beta-trace protein as a potential marker of acute kidney injury: a pilot study. Kidney and Blood Pressure Research. 2021;46(2):185-95.
Lousa I, Reis F, Beirão I, Alves R, Belo L, Santos-Silva A. New potential biomarkers for chronic kidney disease management—A review of the literature. International Journal of Molecular Sciences. 2020;22(1):43.
Mahmoud M, Abu-Shahba N, Azmy O, El-Badri N. Impact of diabetes mellitus on human mesenchymal stromal cell biology and functionality: implications for autologous transplantation. Stem cell reviews and reports. 2019;15(2):194-217.
Marathe PH, Gao HX, Close KL. American D iabetes A ssociation S tandards of M edical C are in D iabetes 2017. Wiley Online Library; 2017.
Motawi TK, Shehata NI, ElNokeety MM, El-Emady YF. Potential serum biomarkers for early detection of diabetic nephropathy. diabetes research and clinical practice. 2018;136:150-8.
Obert LA, Elmore SA, Ennulat D, Frazier KS. A Review of Specific Biomarkers of Chronic Renal Injury and Their Potential Application in Nonclinical Safety Assessment Studies. Toxicologic pathology. 2021;49(5):996-1023.
Ohiri J, Orluwene C. THE ROLE OF BETA TRACE PROTEIN (BTP) IN THE DETECTION OF DIABETIC NEPHROPATHY. Journal of Molecular Pathology and Biochemistry. 2021;22(6):232111373.
Qamar A, Hayat A, Ahmad TM, Khan A, ul Hasnat MN, Tahir S. Serum cystatin C as an early diagnostic biomarker of diabetic kidney disease in type 2 diabetic patients. Journal of the College of Physicians and Surgeons Pakistan. 2018;28(4):288-92.
Reiss AB, Miyawaki N, Moon J, Kasselman LJ, Voloshyna I, D'Avino Jr R, et al. CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies. Atherosclerosis. 2018;278:49-59.
Sajjad K Shael MKR, Sabah M Saeedi. Role of Serum B Trace Protein and Neutrophil Gelatinase Associated Lipocalin in Early Diabetic Nephropathy in Type 2 Diabetes of Iraqi Patients. Journal of Research in Medical and Dental Science. 2020;8 (7):526-33.
Sapkota S, Khatiwada S, Shrestha S, Baral N, Maskey R, Majhi S, et al. Diagnostic Accuracy of Serum Cystatin C for Early Recognition of Nephropathy in Type 2 Diabetes Mellitus. International Journal of Nephrology. 2021;2021.
Saraswati, P. A. I. ., Gunawan, I. M. K., & Budiyasa, D. G. A. (2021). Overview of glomerulus filtration in type 2 of diabetes mellitus at Sanjiwani Gianyar hospital year of 2018-2019. International Journal of Health & Medical Sciences, 4(1), 50-55. https://doi.org/10.31295/ijhms.v4n1.726
Song W-L, Ricciotti E, Liang X, Grosser T, Grant GR, FitzGerald GA. Lipocalin-like prostaglandin D synthase but not hemopoietic prostaglandin D synthase deletion causes hypertension and accelerates thrombogenesis in mice. Journal of Pharmacology and Experimental Therapeutics. 2018;367(3):425-32.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864
Wajda J, Dumnicka P, Sporek M, Maziarz B, Kolber W, Ząbek-Adamska A, et al. Does beta-trace protein (BTP) outperform cystatin C as a diagnostic marker of acute kidney injury complicating the early phase of acute pancreatitis? Journal of Clinical Medicine. 2020;9(1):205.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
